ANNA MAROTO GONZALEZ

Casellas A, Martínez C, Amigó J, Ferrer R, Martí L, Merced C, Medina MC, Molinero I, Calveiro M, Maroto A, Del Barco E, Carreras E, Goya M

Evaluation of an Alternative Screening Method for Gestational Diabetes Diagnosis During the COVID-19 Pandemic (DIABECOVID STUDY): An Observational Cohort Study.

Diagnostics, 2025, 15 dx.doi.org/10.3390/diagnostics15020189

Investigación Metabólica y Maternofetal

Garcia-Manau P, Bonacina E, Martin-Alonso R, Martin L, Palacios A, Sanchez-Camps ML, Lesmes C, Hurtado I, Perez E, Tubau A, Ibañez P, Alcoz M, Valiño N, Moreno E, Borrero C, Garcia E, Lopez-Quesada E, Diaz S, Broullon JR, Teixidor M, Chulilla C, Ferrer-Costa R, Gil MM, Lopez M, Ramos-Forner GM, Blanco JE, Moreno A, Lázaro-Rodríguez M, Vaquerizo O, Soriano B, Fabre M, Gomez-Valencia E, Cuiña A, Alayon N, Sainz-Bueno JA, Vives A, Esteve E, Ocaña V, López MÁ, Maroto A, Carreras E, Mendoza M

Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial.

NATURE MEDICINE, 2025, 31, 1008-1015 dx.doi.org/10.1038/s41591-024-03421-9

Investigación Metabólica y Maternofetal

Bonacina E, Armengol-Alsina M, Garcia-Manau P, López M, Rodriguez-Zurita A, Vives À, Lopez-Quesada E, Ricart M, Maroto A, de Mingo L, Pintado E, Arias-Garcia A, Martín L, Chulilla-Pérez C, Garcia E, Pallarols M, Vidal-Sagnier L, Teixidor M, Orizales-Lago C, Pérez-Gomez A, Ocaña V, Puerto L, Millán P, Diaz S, Del Barco E, Dalmau M, Rolle V, Carreras E, Suy A, Mendoza M

Aspirin Discontinuation at 24-28 Weeks and Placental Biomarker Trajectories: Post Hoc Analysis of a Randomised Trial.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2025 dx.doi.org/10.1111/1471-0528.70040

Trastornos del neurodesarrollo , Investigación Metabólica y Maternofetal

Martínez-Diago, C, Mademont-Soler, I, Bonmati, A, Rodo, C, Alberch, A, Obon, M, Fuertes, B, Maroto, A

Novel variant in <i>ACTA1</i> identified in a fetus with akinesia deformation sequence and cortical development delay

PRENATAL DIAGNOSIS, 2024, 44, 996-998 dx.doi.org/10.1002/pd.6568

Nefrología , Investigación Metabólica y Maternofetal

Bonmatí-Santané, A, López, RC, Saltos, JJA, Martínez, JC, Paez, CN, Sánchez, JP, Figueredo, NV, González, AM

Managing a Pregnancy in the Presence of the Rare Blood Group Antibody PP1Pk

Womens Health Reports, 2024, 5, 319-323 dx.doi.org/10.1089/whr.2023.0120

Investigación Metabólica y Maternofetal

Cabezas M, Diez Y, Martinez-Diago C, Maroto A

A benchmark for 2D foetal brain ultrasound analysis.

Scientific Data, 2024, 11, 923-923 dx.doi.org/10.1038/s41597-024-03774-3

Investigación Metabólica y Maternofetal

Ricart, M, Bonacina, E, Garcia-Manau, P, López, M, Caamina, S, Vives, A, Lopez-Quesada, E, Maroto, A, de Mingo, L, Pintado, E, Ferrer-Costa, R, Martín, L, Rodriguez-Zurita, A, Garcia, E, Pallarols, M, Pratcorona, L, Teixidor, M, Orizales-Lago, C, Ocaña, V, del Barco, E, Carreras, E, Suy, A, Mendoza, M

Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2024, 103, 2273-2280 dx.doi.org/10.1111/aogs.14955

Investigación Metabólica y Maternofetal

Bonacina E, Garcia-Manau P, López M, Caamiña S, Vives À, Lopez-Quesada E, Ricart M, Maroto A, de Mingo L, Pintado E, Castillo-Ribelles L, Martín L, Rodriguez-Zurita A, Garcia E, Pallarols M, Vidal-Sagnier L, Teixidor M, Orizales-Lago C, Pérez-Gomez A, Ocaña V, Puerto L, Millán P, Alsius M, Diaz S, Maiz N, Carreras E, Suy A, Mendoza M

Mid-trimester uterine artery Doppler for aspirin discontinuation in pregnancies at high risk for preterm pre-eclampsia: Post-hoc analysis of StopPRE trial

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131, 334-342 dx.doi.org/10.1111/1471-0528.17631

Endocrinología pediátrica , Investigación Metabólica y Maternofetal

Mas-Parés, B, Carreras-Badosa, G, Gómez-Vilarrubla, A, Maroto, A, Prats-Puig, A, Martínez-Diago, C, de Zegher, F, Ibáñez, L, Bassols, J, López-Bermejo, A

Placental mest gene expression is associated with postnatal growth and obesity

HORMONE RESEARCH IN PAEDIATRICS, 2023, 96, 63-63

Investigación Metabólica y Maternofetal

Garcia-Manau P, Bonacina E, Serrano B, Caamiña S, Ricart M, Lopez-Quesada E, Vives À, Lopez M, Pintado E, Maroto A, Catalan S, Dalmau M, Del Barco E, Hernandez A, Miserachs M, San Jose M, Armengol-Alsina M, Carreras E, Mendoza M

Clinical effectiveness of routine first-trimester combined screening for pre-eclampsia in Spain with the addition of placental growth factor.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2023, 102, 1711-1718 dx.doi.org/10.1111/aogs.14687

Directori

Publicacions

Evaluation of an Alternative Screening Method for Gestational Diabetes Diagnosis During the COVID-19 Pandemic (DIABECOVID STUDY): An Observational Cohort Study.

Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial.

Aspirin Discontinuation at 24-28 Weeks and Placental Biomarker Trajectories: Post Hoc Analysis of a Randomised Trial.

Novel variant in <i>ACTA1</i> identified in a fetus with akinesia deformation sequence and cortical development delay

Managing a Pregnancy in the Presence of the Rare Blood Group Antibody PP1Pk

A benchmark for 2D foetal brain ultrasound analysis.

Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial

Mid-trimester uterine artery Doppler for aspirin discontinuation in pregnancies at high risk for preterm pre-eclampsia: Post-hoc analysis of StopPRE trial

Placental mest gene expression is associated with postnatal growth and obesity

Clinical effectiveness of routine first-trimester combined screening for pre-eclampsia in Spain with the addition of placental growth factor.

Formulari de contacte

Conoce el IDIBGI!